Frequencies of Histo-pathological Findings in Patients With Paraquat Toxicity
NCT01153230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2010-06-30
Summary
The purpose of this study is to determine frequencies of histo-pathological findings in dead poisoned patients and evaluate their relationships with age, gender, dosage of poisoning, time of admission and time of death.
Conditions
- Paraquat Toxicity
Sponsors & Collaborators
-
Isfahan University of Medical Sciences
lead OTHER
Principal Investigators
-
hamidreza shemshaki, MD · MD,research comittee
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-12-31
- Primary Completion
- 2008-11-30
- Completion
- 2008-11-30
Countries
- Iran
Study Locations
More Related Trials
-
Parasitism & COVID19 Vaccines: New Challenge.
NCT05185778 ·Status: NOT_YET_RECRUITING
-
Study on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Humans by a Bug, Using Information From Patient Medical Records in Argentina
NCT03784391 ·Status: COMPLETED
-
Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control
NCT00463632 ·Status: COMPLETED
-
New Therapies and Biomarkers for Chagas Infection
NCT03981523 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil
NCT00403611 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Study of Clinical Practice and Management of Imported Schistosomiasis in France
NCT04810741 ·Status: COMPLETED
-
Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan
NCT03208543 ·Status: TERMINATED ·Phase: PHASE3
-
Immunochromatography Versus Microscopy for Diagnosis of Entamoeba Histolytica/Dispar Infection.
NCT04759937 ·Status: UNKNOWN
-
Health Benefits of Repeated Treatment in Pediatric Schistosomiasis
NCT01424410 ·Status: COMPLETED
-
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
NCT01541631 ·Status: UNKNOWN ·Phase: NA
-
Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma
NCT01163877 ·Status: COMPLETED ·Phase: NA
-
Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique
NCT00231322 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya
NCT00463307 ·Status: COMPLETED
-
Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis
NCT02734186 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy of Mirazid for Schistosomiasis Treatment
NCT01529710 ·Status: COMPLETED ·Phase: PHASE3
-
Monitoring Drug Efficacy and Anthelmintic Resistance in Soil-transmitted Helminth Programs
NCT04177654 ·Status: COMPLETED
-
Hookworm Immune Regulation Project
NCT02262403 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
NCT00906880 ·Status: COMPLETED ·Phase: PHASE4
-
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis
NCT01593722 ·Status: COMPLETED ·Phase: PHASE4
-
Seroprevalence of Leptospirosis in Val Müstair, Switzerland
NCT05300425 ·Status: COMPLETED
-
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
NCT00215267 ·Status: COMPLETED ·Phase: NA
-
Schistosoma Mansoni Morbidity in Children Aged 1-5 Years
NCT01901484 ·Status: COMPLETED ·Phase: PHASE2
-
Health Education Model Led by Community Health Volunteers.
NCT06312462 ·Status: COMPLETED ·Phase: NA
-
Hantavirus Transmission in Households in Chile
NCT00533767 ·Status: TERMINATED
-
Treatment of Patients With Active Neurocysticercosis in Eastern Africa
NCT03834337 ·Status: COMPLETED